Eglucent Mix 50 Kwikpen

Composition of Eglucent Mix 50 Kwikpen

Eglucent Mix 50 Kwikpen contains Insulin lispro protamine suspension 50% + Insulin lispro 50% (100 IU/mL). It belongs to the Insulin analogue (premixed rapid-acting + intermediate-acting insulin) class of medicines.

Uses of Eglucent Mix 50 Kwikpen

Treatment of diabetes mellitus (type 1 and type 2) to improve blood glucose control; used when a premixed rapid-acting/ intermediate-acting insulin regimen is advised.

Key benefits

• Controls post-meal blood sugar spikes
• Provides basal glucose control between meals
• Convenient premixed insulin pen for fewer injections
• Helps achieve improved HbA1c when used with diet and exercise

How Eglucent Mix 50 Kwikpen works

This premixed insulin contains insulin lispro (rapid-acting) for controlling post-meal blood sugar spikes and insulin lispro protamine (intermediate-acting) for basal control between meals and overnight. It increases peripheral glucose uptake and reduces hepatic glucose production, lowering blood glucose.

How to take Eglucent Mix 50 Kwikpen

For subcutaneous use only via prefilled KwikPen. Inject as prescribed, typically within 15 minutes before a meal (or immediately after as advised). Do not mix with other insulins in the pen; rotate injection sites (abdomen, thigh, upper arm); prime the pen before each injection and use a new needle each time. Do not use intravenously or in insulin pumps.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Take the missed dose of Eglucent Mix as soon as you remember. If it is almost time for the next dose, skip the missed one and carry on with the usual schedule. Do not take two doses together to make up for a missed dose.

If you take too much

Taking more Eglucent Mix than prescribed can be harmful. If you suspect an overdose, contact a doctor or go to the nearest emergency department at once, and carry the pack or strip with you. In India the emergency number is 112.

Side effects of Eglucent Mix 50 Kwikpen

Most side effects of Eglucent Mix are mild and settle as the body adjusts. Reported side effects include:

• Hypoglycaemia
• injection site reactions (pain/redness/swelling)
• weight gain
• lipodystrophy
• itching/rash
• oedema

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Eglucent Mix 50 Kwikpen

Warnings and precautions

Risk of hypoglycaemia—monitor glucose regularly and carry fast-acting sugar. Use with caution in renal or hepatic impairment and in elderly patients (may need dose adjustment). Do not use during episodes of hypoglycaemia. Switching insulin brand/type or changes in dose, diet, activity, or illness can alter insulin needs—do only under medical supervision. Watch for allergic reactions; rotate sites to reduce lipodystrophy. Use caution while driving/operating machinery if prone to hypoglycaemia.

Interactions with other medicines

Other antidiabetic drugs (increased hypoglycaemia risk), ACE inhibitors and salicylates (may increase hypoglycaemia), beta-blockers (may mask hypoglycaemia symptoms), corticosteroids/thyroid hormones/thiazide diuretics/sympathomimetics (may increase glucose and insulin requirement), alcohol (may increase hypoglycaemia), MAO inhibitors (may increase hypoglycaemia)

How to store Eglucent Mix 50 Kwikpen

Store unopened pens refrigerated at 2–8°C; do not freeze; protect from light. After first use, keep at room temperature (below 30°C) away from heat/light and use within 28 days (do not refrigerate if in use). Keep pen capped; discard if frozen or exposed to excessive heat.

Manufacturer and class

Manufacturer:

LUPIN LAB

Therapeutic class:

Antidiabetic

Drug class:

Insulin analogue (premixed rapid-acting + intermediate-acting insulin)